BR0211545A - Método e composição para tratamento de hipertensão ocular e glaucoma - Google Patents

Método e composição para tratamento de hipertensão ocular e glaucoma

Info

Publication number
BR0211545A
BR0211545A BR0211545-0A BR0211545A BR0211545A BR 0211545 A BR0211545 A BR 0211545A BR 0211545 A BR0211545 A BR 0211545A BR 0211545 A BR0211545 A BR 0211545A
Authority
BR
Brazil
Prior art keywords
treatment
glaucoma
composition
ocular hypertension
present
Prior art date
Application number
BR0211545-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Ryuji Ueno
Original Assignee
Sucampo Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo Ag filed Critical Sucampo Ag
Publication of BR0211545A publication Critical patent/BR0211545A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR0211545-0A 2001-07-31 2002-07-30 Método e composição para tratamento de hipertensão ocular e glaucoma BR0211545A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30858901P 2001-07-31 2001-07-31
PCT/JP2002/007699 WO2003011299A2 (fr) 2001-07-31 2002-07-30 Procede et composition pour le traitement de l'hypertension oculaire et des glaucomes

Publications (1)

Publication Number Publication Date
BR0211545A true BR0211545A (pt) 2004-07-13

Family

ID=23194562

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0211545-0A BR0211545A (pt) 2001-07-31 2002-07-30 Método e composição para tratamento de hipertensão ocular e glaucoma

Country Status (8)

Country Link
EP (1) EP1411950A2 (fr)
JP (1) JP2004538306A (fr)
KR (1) KR20040023707A (fr)
CN (1) CN1646134A (fr)
BR (1) BR0211545A (fr)
CA (1) CA2454422A1 (fr)
MX (1) MXPA04000980A (fr)
WO (2) WO2003011299A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005519978A (ja) * 2002-03-28 2005-07-07 スキャンポ・アーゲー 高眼圧症および緑内障の処置方法
AR043161A1 (es) * 2003-02-14 2005-07-20 Sucampo Pharmaceuticals Inc Composicion oftalmica para tratar hipertension ocular y glaucoma
US7605178B2 (en) * 2006-07-10 2009-10-20 Allergan, Inc. Therapeutic compounds
US20080015219A1 (en) * 2006-07-11 2008-01-17 Allergan, Inc. Therapeutic compounds
WO2008008718A2 (fr) * 2006-07-11 2008-01-17 Allergan, Inc. Composés thérapeutiques
NZ582705A (en) * 2007-07-03 2012-06-29 Allergan Inc Therapeutic substituted cyclopentanes for reducing intraocular pressure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68918391T2 (de) * 1988-10-01 1995-01-19 Ueno Seiyaku Oyo Kenkyujo Kk Okulare hypotensive Mittel.
KR20080012407A (ko) * 2000-03-16 2008-02-11 수캄포 아게 고안압증 및 녹내장 치료용 조성물
US20020035148A1 (en) * 2000-07-20 2002-03-21 Ryuji Ueno Treatment of ocular hypertension

Also Published As

Publication number Publication date
CA2454422A1 (fr) 2003-02-13
EP1411950A2 (fr) 2004-04-28
WO2003011299A3 (fr) 2003-10-30
CN1646134A (zh) 2005-07-27
WO2003011299A2 (fr) 2003-02-13
WO2003011178A2 (fr) 2003-02-13
KR20040023707A (ko) 2004-03-18
JP2004538306A (ja) 2004-12-24
MXPA04000980A (es) 2004-04-20

Similar Documents

Publication Publication Date Title
ECSP034815A (es) "composiciones de timolol y de lipido hipotensivas y los metodos para utilizarlas"
BR9712824A (pt) Composição oftálmica de fator neurotrófico, agente de tratamento de desordem funcional do nervo ótico e método para tratamento de desordem funcional do nervo ótico
BR0008059A (pt) Composições de valdecoxib
KR930001913A (ko) 안염 치료방법
ES2090858T3 (es) Composicion que comprende una fuente de acido graso omega-3 y un estimulador de glutation para el tratamiento de trastornos inmunes e infecciones viricas.
DK1075265T3 (da) Anvendelse af tetracycliner til behandling af sygdom i de Meibomske kirtler
CA2447924A1 (fr) Formulations d'olopatadine a administration topique
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
BRPI0110914B8 (pt) 'composição farmacêutica líquida, processo para preparação da mesma e uso de uma composicão farmacêutica'
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
BR9808016A (pt) Composições e métodos para redução da hipertensão ocular
BR9813811A (pt) "composições farmacêuticas compreendendo micelas que compreendem glicocorticosteróide lipofìlico e apenas um único tensoativo"
ATE227976T1 (de) Lösungen als träger für augenarzneien
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
KR960033452A (ko) 시신경 질환의 치료를 위한 프로스타노산 화합물
FI962493A0 (fi) Alfa-2-adrenoseptoriagonisteina käyttökelpoisia 6-(2-imidatsolinyyliamino)kinoksaliiniyhdisteitä
DK1110554T3 (da) Medicinal præparater til behandling af öjensygdomme
KR890003387A (ko) 국소활성을 갖는 이중-가닥 RMAs조성물
BR0208727A (pt) Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia
BR0211545A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma
JP2003206241A (ja) 眼科用剤
DK1091733T3 (da) (-)-Pseudoephedrin som et sympatomimetisk lægemiddel
BR0108219A (pt) Uso oftálmico de agentes bloqueadores alfa-adrenérgicos
AU609807B2 (en) A composition for the topical treatment of glaucoma or ocular hypertension
BR0211855A (pt) Medicamento e método para tratamento e melhoria da qualidade restauradora do sono

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired